Stock fact sheet · data as of

BrasilAgro - Companhia Brasileira de Propriedades Agrícolas (LND): fair value, margin of safety and Wheel Score

Consumer Defensive · Agricultural Farm Products · Brazil · ADR · Speculative / Distressed

Close3.58
GLS fair value7.283 of 9 models
Margin of safety+51%price below fair value
Wheel Score39No optionscapped: no options
Health3/9Piotroski F-score
Moat0.9/10GLS 10-year score
Market cap$367M33k shares a day
Implied vol.-no listed options
P/E-EPS -0.18
Dividend yield4.09%payout -83%
Beta-0.05moves less than the market
Next earnings-no date recorded

Is LND undervalued?

LND has a margin of safety of 51%: the stock closed at 3.58 on 16 Oct 2026 against a GLS average fair value of 7.28. 2 of the 3 valuation models that produced a number sit above the price. Our screens treat a discount this large as a strong starting point for a cash-secured put, not as a verdict - the fair value is a model output, and a wide gap can mean the models are missing something the market knows.

Only 3 of the nine models produced a value (DCF, 10 Cap, DDM); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files LND under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for LND

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF3.09-14%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap7.67+114%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM11.08+209%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)-5.74-260%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is weak: LND passes 3 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 0.9 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are thin or negative - ROIC -2.7%, ROE -4.6%, ROA -2.5% - with debt at 0.71 times equity and a free-cash-flow yield of 1.6%.

The dividend yield is high at 4.09% (payout ratio -83%). A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.

Institutional ownership scores 1/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score3 / 9ROIC-2.7%
GLS Moat0.9 / 10ROE-4.6%
Debt / equity0.71ROA-2.5%
Free-cash-flow yield1.6%Payout ratio-83%
Institutions1 / 10Insiders · Congress10 · 5 / 10

Wheel Score 39: No options

LND has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 33k shares a day on a market cap of $367M, with a beta of -0.05 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.

PartPointsFrom
Value25 / 2551% margin of safety
Health7 / 20Piotroski 3/9
Moat1 / 15moat 0.9/10
Premium0 / 20no option data
Stability6 / 2033k shares/day, $367M cap, beta -0.05

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for LND in the nightly calendar. The shares go ex-dividend on 23 Oct 2026 (0.0576 per share), so a covered call sold before then carries a small early-assignment risk around that date.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Agricultural Farm Products

The 12 companies below are the closest to BrasilAgro - Companhia Brasileira de Propriedades Agrícolas by market cap within the Agricultural Farm Products industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
VITL
Vital Farms, Inc.
8.9112.57+29%45Weak$383M
AFRI
Forafric Global PLC
11.855.31-123%14No options$320M
VFF
Village Farms International, Inc.
2.564.92+48%72Good$313M
CHSCO
CHS Inc.
25.5827.59+7%39No options$309M
CHSCL
CHS Inc.
25.1027.59+9%39No options$308M
CHSCM
CHS Inc.
22.8427.59+17%39No options$308M
CHSCP
CHS Inc.
25.9227.59+6%39No options$307M
CHSCN
CHS Inc.
23.5527.59+15%39No options$305M
ALCO
Alico, Inc.
37.984.13-821%21No options$282M
LMNR
Limoneira Company
11.822.21-436%23Weak$214M
STNT
Stevia Nutra Corp.
6.370.3488-1725%8No options$162M
DOLE
Dole plc
13.4115.22+12%75Good$1.3B

⚖ Compare LND with 7 of them   All Consumer Defensive stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about LND

Is LND undervalued right now?

By the GLS models, yes: at 3.58 the stock is 51% below the average fair value of 7.28 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of LND and what does it mean?

LND has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for LND?

7.28 per share as of 16 Oct 2026 - the simple average of the 3 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does BrasilAgro - Companhia Brasileira de Propriedades Agrícolas report earnings next?

No upcoming earnings date is recorded for LND in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does LND have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on LND, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.